These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

161 related items for PubMed ID: 29187649

  • 1. [IL-6 promotes gastric cancer cell proliferation and EMT through regulating miR-152/PIK3R3 pathway].
    Sun J, Fu L.
    Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2017 Nov 28; 42(11):1241-1247. PubMed ID: 29187649
    [Abstract] [Full Text] [Related]

  • 2. miR-107 regulates growth and metastasis of gastric cancer cells via activation of the PI3K-AKT signaling pathway by down-regulating FAT4.
    Wang L, Li K, Wang C, Shi X, Yang H.
    Cancer Med; 2019 Sep 28; 8(11):5264-5273. PubMed ID: 31297980
    [Abstract] [Full Text] [Related]

  • 3. MiR-592 Promotes Gastric Cancer Proliferation, Migration, and Invasion Through the PI3K/AKT and MAPK/ERK Signaling Pathways by Targeting Spry2.
    He Y, Ge Y, Jiang M, Zhou J, Luo D, Fan H, Shi L, Lin L, Yang L.
    Cell Physiol Biochem; 2018 Sep 28; 47(4):1465-1481. PubMed ID: 29949784
    [Abstract] [Full Text] [Related]

  • 4. Suppressive effects of microRNA-16 on the proliferation, invasion and metastasis of hepatocellular carcinoma cells.
    Wu WL, Wang WY, Yao WQ, Li GD.
    Int J Mol Med; 2015 Dec 28; 36(6):1713-9. PubMed ID: 26499886
    [Abstract] [Full Text] [Related]

  • 5. Paeoniflorin inhibits human gastric carcinoma cell proliferation through up-regulation of microRNA-124 and suppression of PI3K/Akt and STAT3 signaling.
    Zheng YB, Xiao GC, Tong SL, Ding Y, Wang QS, Li SB, Hao ZN.
    World J Gastroenterol; 2015 Jun 21; 21(23):7197-207. PubMed ID: 26109806
    [Abstract] [Full Text] [Related]

  • 6. Neogenin-1 Promotes Cell Proliferation, Motility, and Adhesion by Up-Regulation of Zinc Finger E-Box Binding Homeobox 1 Via Activating the Rac1/PI3K/AKT Pathway in Gastric Cancer Cells.
    Qu H, Sun H, Wang X.
    Cell Physiol Biochem; 2018 Jun 21; 48(4):1457-1467. PubMed ID: 30064133
    [Abstract] [Full Text] [Related]

  • 7. [Effect of miR-92b on migration, adhesion and invasion of human gastric cancer cell line SGC7901].
    Wang W, Wang C, Jiang Y, Wu B.
    Nan Fang Yi Ke Da Xue Xue Bao; 2014 Dec 21; 34(12):1748-52. PubMed ID: 25537895
    [Abstract] [Full Text] [Related]

  • 8. MicroRNA-92a promotes epithelial-mesenchymal transition through activation of PTEN/PI3K/AKT signaling pathway in non-small cell lung cancer metastasis.
    Lu C, Shan Z, Hong J, Yang L.
    Int J Oncol; 2017 Jul 21; 51(1):235-244. PubMed ID: 28534966
    [Abstract] [Full Text] [Related]

  • 9. F-box protein 11 promotes the growth and metastasis of gastric cancer via PI3K/AKT pathway-mediated EMT.
    Sun C, Tao Y, Gao Y, Xia Y, Liu Y, Wang G, Gu Y.
    Biomed Pharmacother; 2018 Feb 21; 98():416-423. PubMed ID: 29278851
    [Abstract] [Full Text] [Related]

  • 10. miR-224-5p inhibits proliferation, migration, and invasion by targeting PIK3R3/AKT3 in uveal melanoma.
    Li J, Liu X, Li C, Wang W.
    J Cell Biochem; 2019 Aug 21; 120(8):12412-12421. PubMed ID: 30825222
    [Abstract] [Full Text] [Related]

  • 11. Celastrus Orbiculatus Extracts Inhibit the Metastasis through Attenuating PI3K/Akt/mTOR Signaling Pathway in Human Gastric Cancer.
    Qian Y, Yan Y, Lu H, Zhou T, Lv M, Fang C, Hou J, Li W, Chen X, Sun H, Li Y, Wang Z, Zhao N, Gu Y, Ding Y, Liu Y.
    Anticancer Agents Med Chem; 2019 Aug 21; 19(14):1754-1761. PubMed ID: 31364518
    [Abstract] [Full Text] [Related]

  • 12. Astragaloside IV inhibits TGF-β1-induced epithelial-mesenchymal transition through inhibition of the PI3K/Akt/NF-κB pathway in gastric cancer cells.
    Zhu J, Wen K.
    Phytother Res; 2018 Jul 21; 32(7):1289-1296. PubMed ID: 29480652
    [Abstract] [Full Text] [Related]

  • 13. BMP2 accelerates the motility and invasiveness of gastric cancer cells via activation of the phosphatidylinositol 3-kinase (PI3K)/Akt pathway.
    Kang MH, Kim JS, Seo JE, Oh SC, Yoo YA.
    Exp Cell Res; 2010 Jan 01; 316(1):24-37. PubMed ID: 19835871
    [Abstract] [Full Text] [Related]

  • 14. miR-300 regulates the epithelial-mesenchymal transition and invasion of hepatocellular carcinoma by targeting the FAK/PI3K/AKT signaling pathway.
    Wang R, Yu Z, Chen F, Xu H, Shen S, Chen W, Chen L, Su Q, Zhang L, Bi J, Zeng W, Li W, Huang X, Wang Q.
    Biomed Pharmacother; 2018 Jul 01; 103():1632-1642. PubMed ID: 29864952
    [Abstract] [Full Text] [Related]

  • 15. MiR-125 inhibited cervical cancer progression by regulating VEGF and PI3K/AKT signaling pathway.
    Fu K, Zhang L, Liu R, Shi Q, Li X, Wang M.
    World J Surg Oncol; 2020 May 30; 18(1):115. PubMed ID: 32473637
    [Abstract] [Full Text] [Related]

  • 16. MiR-19a promotes epithelial-mesenchymal transition through PI3K/AKT pathway in gastric cancer.
    Lu WD, Zuo Y, Xu Z, Zhang M.
    World J Gastroenterol; 2015 Apr 21; 21(15):4564-73. PubMed ID: 25914465
    [Abstract] [Full Text] [Related]

  • 17. [miRNA-96-5p inhibits the proliferation and migration of gastric cancer cells by targeting FoxQ1].
    Yang XY, Li N, Deng WY, Ma YJ, Han XL, Zhang ZY, Xie JL, Luo SX.
    Zhonghua Zhong Liu Za Zhi; 2019 Mar 23; 41(3):193-199. PubMed ID: 30917455
    [Abstract] [Full Text] [Related]

  • 18. microRNA-107 inhibits gastric cancer cell proliferation and metastasis by targeting PI3K/AKT pathway.
    Cheng F, Yang Z, Huang F, Yin L, Yan G, Gong G.
    Microb Pathog; 2018 Aug 23; 121():110-114. PubMed ID: 29715534
    [Abstract] [Full Text] [Related]

  • 19. HOXD-AS1 promotes the epithelial to mesenchymal transition of ovarian cancer cells by regulating miR-186-5p and PIK3R3.
    Dong S, Wang R, Wang H, Ding Q, Zhou X, Wang J, Zhang K, Long Y, Lu S, Hong T, Ren H, Wong K, Sheng X, Wang Y, Zeng Y.
    J Exp Clin Cancer Res; 2019 Mar 01; 38(1):110. PubMed ID: 30823895
    [Abstract] [Full Text] [Related]

  • 20. LncRNA DLEU2 silencing impedes the migration, invasion and EMT in gastric cancer cell by suppressing PI3K/AKT signaling pathway.
    Hu J, Wang M, Yang Y, Xing Y, Li S.
    Immunopharmacol Immunotoxicol; 2022 Oct 01; 44(5):719-731. PubMed ID: 35736813
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.